| 英文名称 | 中文名称 | CAS | MF |
|
Oxazolo[4,5-b]pyridin-2-amine, N,N-dimethyl- (9CI)
|
|
652143-61-8
|
C8H9N3O
|
|
2-(S)-(2-Hydroxyethyl)piperidine-(S)-10-camphorsulphonate
|
2-(2-羟基乙基)哌啶鎓 (7,7-二甲基-2-氧代双环[2.2.1]庚-1-基)甲烷磺酸盐
|
652144-68-8
|
C10H16O4S.C7H15NO
|
|
(3aS,8bS)-4-(4-(2,2-diphenylvinyl)phenyl)-1,2,3,3a,4,8b-hexahydrocyclopenta[b]indole-7-carbaldehyde
|
(3AS,8BS)-4-(4-(2,2-二苯基乙烯基)苯基)-1,2,3,3A,4,8B-六氢环戊[B]吲哚-7-甲醛
|
652145-27-2
|
C32H27NO
|
|
D-102 Dye
|
吲哚啉D-102染料
|
652145-28-3
|
C37H30N2O3S2
|
|
D 131
|
D 131
|
652145-29-4
|
C35H28N2O2
|
|
Cyclohexaneacetic acid, 1-methoxy-alpha-methyl-, methyl ester (9CI)
|
|
652146-28-6
|
C11H20O3
|
|
(1R,5S,7R)-tert-Butyl 7-hydroxy-3-oxa-9-azabicyclo[3.3.1]nonane-9-carboxylate
|
(1R,5S,7R)-TERT-BUTYL 7-HYDROXY-3-OXA-9-AZABICYCLO[3.3.1]NONANE-9-CARBOXYLATE
|
652148-14-6
|
C12H21NO4
|
|
6-Chloropyridine-2-boronic acid
|
6-氯吡啶-2-硼酸
|
652148-90-8
|
C5H5BClNO2
|
|
5-Chloropyridine-2-boronic acid
|
5-氯吡啶-2-硼酸
|
652148-91-9
|
C5H5BClNO2
|
|
6-Chloropyridine-2-boronic acid pinacol ester
|
6-氯吡啶-2-硼酸频哪酯
|
652148-92-0
|
C11H15BClNO2
|
|
5-Chloropyridine-2-boronic acid pinacol ester
|
5-氯吡啶-2-硼酸频哪醇酯
|
652148-93-1
|
C11H15BClNO2
|
|
5-Bromopyridine-2-boronic acid
|
5-溴吡啶-2-硼酸
|
652148-97-5
|
C5H5BBrNO2
|
|
5-Bromopyridine-2-boronic acid pinacol ester
|
5-溴吡啶-2-硼酸频哪醇酯
|
652148-98-6
|
C11H15BBrNO2
|
|
2-Oxetanone,3-ethyl-4-(2-phenylethyl)-,(3R,4S)-(9CI)
|
|
652150-88-4
|
C13H16O2
|
|
2-Oxetanone,3-ethyl-4-[(phenylmethoxy)methyl]-,(3R,4R)-(9CI)
|
|
652150-92-0
|
C13H16O3
|
|
Phosphoramidous dichloride, (1-ethyl-2(1H)-pyrimidinylidene)- (9CI)
|
|
652152-25-5
|
C6H8Cl2N3P
|
|
(3aR,4R,5R,6aS)-4-[(1E)-4-(3-Chlorophenoxy)-3-hydroxy-1-buten-1-yl]hexahydro-5-hydroxy-2H-cyclopenta[b]furan-2-one
|
(3AR,4R,5R,6AS)-4-[(1E)-4-(3-氯苯氧基)-3-羟基-1-丁烯基]六氢-5-羟基-2H-环戊并[B]呋喃-2-酮
|
652152-39-1
|
C17H19ClO5
|
|
ZanoliMuMab
|
ZanoliMuMab
|
652153-01-0
|
|
|
1,4-Cyclohexadiene-1-carboxaldehyde,4-methoxy-3,3-dimethyl-6-oxo-(9CI)
|
|
652153-12-3
|
C10H12O3
|
|
3-(4-(4-(3-chlorophenylaMino)-1,3,5-triazin-2-yl)pyridin-2-ylaMino)propan-1-ol
|
3-[[4-[4-[(3-氯苯基)氨基]-1,3,5-噻嗪-2-基]-2-吡啶]氨基]-1-丙醇
|
652153-35-0
|
C17H17ClN6O
|
|
N-(3-chlorophenyl)-4-(2-chloropyridin-4-yl)-1,3,5-triazin-2-amine
|
N-(3-氯苯基)-4-(2-氯吡啶-4-基)-1,3,5-三嗪-2-胺
|
652153-37-2
|
C14H9Cl2N5
|
|
tert-Butyl (6-chloropyrazin-2-yl)carbamate
|
(6-氯吡嗪-2-基)氨基甲酸叔丁酯
|
652153-48-5
|
C9H12ClN3O2
|
|
tert-butyl (2,3-dihydrobenzo[b][1,4]dioxin-6-yl)carbamate
|
|
652153-62-3
|
C13H17NO4
|
|
magnesium trifluoroacetylacetonate hydrate
|
1,1,1-三氟-乙酰丙酮镁 水合物
|
652154-06-8
|
C10H10F6MgO5
|
|
Isatin-5-sulfonic acid sodium salt dihydrate
|
靛红-5-硫酸钠盐二水
|
652154-08-0
|
C8H8NNaO6S
|
|
BRUCINE SULFATE HYDRATE
|
硫酸二甲基马钱子碱酯水合物
|
652154-10-4
|
C23H28N2O8S
|
|
5 10 15 20-Tetraphenyl-21h 23H-porphine&
|
5,10,15,20-四苯基-21H,23H-卟吩-P,P`,P``,P```-四磺酸基四钠盐水合物
|
652154-11-5
|
C44H26N4O12S4.4Na.5H2O
|
|
SODIUM METATUNGSTATE HYDRATE, CRYSTALLINE
|
|
652154-12-6
|
H2NaO41W12(-5)
|
|
CYTIDINE 5'-TRIPHOSPHATE DISODIUM
|
胞嘧啶核苷5`-三磷酸二钠盐水合物
|
652154-13-7
|
C9H14N3Na2O14P3
|
|
Urea, N-[(E)-(methoxyimino)methyl]-N,N-dimethyl- (9CI)
|
|
652154-31-9
|
C5H11N3O2
|
|
Carbamothioic acid, methyl-, S-(4-methoxyphenyl) ester (9CI)
|
|
652154-32-0
|
C9H11NO2S
|
|
Urea, [(E)-(methoxyimino)methyl]trimethyl- (9CI)
|
|
652154-47-7
|
C6H13N3O2
|
|
Cyclopentane, 3-ethylidene-1,1-bis(methoxymethyl)-4-methyl-, (3E)- (9CI)
|
|
652154-92-2
|
C12H22O2
|
|
Cyclopentanemethanol, 3-hydroxy-4,4-dimethyl-2-methylene-, (1R,3R)-rel- (9CI)
|
|
652155-28-7
|
C9H16O2
|
|
2'-DEOXYCYTIDINE MONOHYDRATE, 99+%
|
2' -脱氧胞苷水合物
|
652157-52-3
|
C9H15N3O5
|
|
Ethenone, [(1R,5S,6S)-6-ethenylbicyclo[3.1.0]hex-1-yl]-, rel- (9CI)
|
|
652158-68-4
|
C10H12O
|
|
Ethenone, [(1R,5S,6S)-5-methyl-6-(1-methylethenyl)bicyclo[3.1.0]hex-1-yl]-, rel- (9CI)
|
|
652158-71-9
|
C12H16O
|
|
ethyl 5-(2-(tert-butoxycarbonylamino)ethyl)-1,2,4-oxadiazole-3-carboxylate
|
5-[2-[(叔丁氧羰基)氨基]乙基]-1,2,4-恶二唑-3-羧酸乙酯
|
652158-82-2
|
C12H19N3O5
|
|
Ethyl5-(aminomethyl)-1,3,4-oxadiazole-2-carboxylatehydrochloride
|
5-氨甲基-1,3,4-恶二唑-2-甲酸乙酯盐酸盐
|
652158-84-4
|
C6H10ClN3O3
|
|
1H-Indazol-6-amine,1-cyclopentyl-3-ethyl-(9CI)
|
|
652158-88-8
|
C14H19N3
|
|
(10-broModecyl)triethoxysilane
|
10-溴癸基三乙氧基硅烷
|
652159-43-8
|
C16H35BrO3Si
|
|
2-Bromo-5-fluoro-3-nitropyridine
|
2-溴-5-氟-3-硝基吡啶
|
652160-72-0
|
C5H2BrFN2O2
|
|
Xanthine, 3-allyl-1-ethyl- (5CI)
|
|
652161-59-6
|
C10H12N4O2
|
|
7-Benzyl-8-[4-(4-methoxyphenyl)piperazin-1-yl]-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione
|
|
652166-14-8
|
C25H28N6O3
|
|
1H-Isoindole-4-carboxylicacid,2-ethyl-2,3,3a,4,7,7a-hexahydro-1,3-dioxo-,(3aR,4S,7aR)-rel-(9CI)
|
|
652169-29-4
|
C11H13NO4
|
|
Cyclohexanecarboxylic acid, 1-[(2-furanylcarbonyl)amino]-, methyl ester (9CI)
|
|
652171-09-0
|
C13H17NO4
|
|
Cyclohexanecarboxylic acid, 1-[[(5-methyl-3-isoxazolyl)carbonyl]amino]- (9CI)
|
|
652171-59-0
|
C12H16N2O4
|
|
Cyclohexanecarboxylic acid, 1-[[(2-methyl-3-furanyl)carbonyl]amino]- (9CI)
|
|
652171-86-3
|
C13H17NO4
|
|
Cyclohexanecarboxylic acid, 1-[[(5-methyl-2-furanyl)carbonyl]amino]- (9CI)
|
|
652171-88-5
|
C13H17NO4
|
|
Cyclohexanecarboxylic acid, 1-[(4-pyridinylcarbonyl)amino]- (9CI)
|
|
652172-15-1
|
C13H16N2O3
|
|
Cyclohexanecarboxylic acid, 1-[(2-pyridinylcarbonyl)amino]- (9CI)
|
|
652172-20-8
|
C13H16N2O3
|
|
Cyclohexanecarboxylic acid, 1-[(cyclohexylcarbonyl)amino]- (9CI)
|
|
652172-94-6
|
C14H23NO3
|
|
7-Fluoro-7-deaza-2'-deoxyadenosine
|
7-Fluoro-7-deaza-2'-deoxyadenosine
|
652965-07-6
|
C11H13FN4O3
|
|
N'-Hydroxy-4-[2-nitro-4-(trifluoromethyl)phenoxy]benzenecarboximidamide
|
|
652965-53-2
|
C14H10F3N3O4
|
|
(3-(2,6-Dichlorophenyl)-5-methylisoxazol-4-yl)-N-(5-bromo(2-pyridyl))formamide
|
|
652965-63-4
|
C16H10BrCl2N3O2
|
|
Atto 425
|
Atto 425
|
652966-03-5
|
C22H27NO6
|
|
4-[(4-Chloro-2,5-dimethylphenyl)thio]-3-nitrobenzoic acid
|
|
652967-64-1
|
C15H12ClNO4S
|
|
4-[(4-(((1,1-Dimethylethyl)oxidoimino)methyl)phenoxy)butyl]triphenylphosphonium bromide
|
MITOPBN
|
652968-37-1
|
C33H37NO2P.Br
|
|
Benzoic acid, 3,5-bis(ethylamino)- (9CI)
|
|
652968-38-2
|
C11H16N2O2
|
|
1H-Benzimidazole,1-(trifluoromethyl)-(9CI)
|
(9CI)-1-(三氟甲基)-1H-苯并咪唑
|
652968-46-2
|
C8H5F3N2
|
|
(3R,4S)-1-(tert-Butoxycarbonyl)-4-phenylpiperidine-3-carboxylic acid
|
|
652971-19-2
|
C17H23NO4
|
|
(3S,4R)-1-(tert-butoxycarbonyl)-4-phenylpiperidine-3-carboxylic acid
|
(3S,4R)-1-(叔丁氧基羰基)-4-苯基哌啶-3-羧酸
|
652971-20-5
|
C17H23NO4
|
|
(3R,4S)-4-Phenylpyrrolidine-3-carboxylic acid
|
(3R,4S)-4-苯基吡咯烷-3-羧酸
|
652971-46-5
|
C11H13NO2
|
|
8(5H)-Quinolinone,7-(aminomethyl)-6,7-dihydro-(9CI)
|
|
652972-06-0
|
C10H12N2O
|
|
1-Propanone,3-amino-1-(2-pyridinyl)-(9CI)
|
|
652972-07-1
|
C8H10N2O
|
|
Calhex 231
|
Calhex 231
|
652973-93-8
|
C25H27ClN2O
|
|
Thiophene, 2-(1-butynyl)- (9CI)
|
|
652974-09-9
|
C8H8S
|
|
Benzaldehyde, 4-(1-butynyl)- (9CI)
|
|
652974-14-6
|
C11H10O
|
|
Glycine, N-(2-amino-2-oxoethyl)-, ethyl ester (9CI)
|
|
652975-29-6
|
C6H12N2O3
|
|
(Z)-Ethyl 5-hydroxy-8-oxo-8,9-dihydro-7H-pyrido[2,3-b]azepine-6-carboxylate
|
|
652976-27-7
|
C12H12N2O4
|
|
(E)-5-Hydroxy-7H-pyrido[2,3-b]azepin-8(9H)-one
|
|
652976-28-8
|
C9H8N2O2
|
|
1H-Benzimidazole,1-(3-furanylmethyl)-(9CI)
|
|
652976-75-5
|
C12H10N2O
|
|
5-(4-(Trifluoromethyl)phenyl)-1,2,4-oxadiazole-3-carboxylic acid
|
|
652979-81-2
|
C10H5F3N2O3
|
|
2-(4-bromo-3,5-dimethyl-1H-pyrazol-1-yl)ethanol
|
2-(4-溴-3,5-二甲基-1H-吡唑-1-基)乙-1-醇
|
652982-93-9
|
C7H11BrN2O
|
|
Pyridine, 2-ethyl-6-[(1E)-2-phenylethenyl]- (9CI)
|
|
652987-50-3
|
C15H15N
|
|
Pyridine, 2-methyl-6-(1E)-1-propenyl- (9CI)
|
|
652987-55-8
|
C9H11N
|
|
Pyridine, 2-methyl-6-(1Z)-1-propenyl- (9CI)
|
|
652987-56-9
|
C9H11N
|
|
Milveterol
|
化合物 MILVETEROL
|
652990-07-3
|
C25H29N3O4
|
|
2,4-IMidazolidinedione, 1-[(4-Methoxyphenyl)Methyl]-
|
|
652992-63-7
|
C11H12N2O3
|
|
(E)-4-(2-Phenoxyphenyl)-3-buten-2-one
|
(E)-4-(2-苯氧基苯基)丁-3-烯-2-酮
|
652994-30-4
|
C16H14O2
|
|
6H-1,3-Oxazin-6-one, 2,3-dihydro-2-(iminoethylidene)-4-methyl-, (2E)- (9CI)
|
|
652995-60-3
|
C7H8N2O2
|
|
2,4(1H,3H)-Pyridinedione,3-(iminomethyl)-(9CI)
|
|
652995-62-5
|
C6H6N2O2
|
|
Benzoic acid, 4-cyano-2-(ethylamino)-, methyl ester (9CI)
|
|
652997-54-1
|
C11H12N2O2
|
|
Benzonitrile, 4-iodo-3-methoxy-
|
4-碘-3-甲氧基苄腈
|
652997-56-3
|
C8H6INO
|
|
Bis(4-nitrobenzyl)Malonic acid
|
BIS(4-NITROBENZYL)MALONIC ACID
|
653306-99-1
|
C17H14N2O8
|
|
2-Methyl-4-(tributylstannyl)thiazole
|
2-METHYL-4-(TRIBUTYLSTANNYL)THIAZOLE
|
653564-10-4
|
C16H31NSSn
|
|
5-Oxocanol,4-methoxy-3,3-dimethyl-7-methylene-,(4R,5R)-(9CI)
|
|
653568-47-9
|
C11H20O3
|
|
2-Furanol, tetrahydro-3-methoxy-4,4-dimethyl-, (3R)- (9CI)
|
|
653568-66-2
|
C7H14O3
|
|
5-chloro-2-methoxy-3-methylbenzoic acid
|
5-氯-2-甲氧基-3-甲基苯甲酸
|
653569-18-7
|
C9H9ClO3
|
|
3,4-Pyrrolidinediol,2-[2-(phenylamino)ethyl]-,(2S,3R,4S)-(9CI)
|
|
653570-89-9
|
C12H18N2O2
|
|
3,4-Pyrrolidinediol, 2-[2-[(2-hydroxybutyl)amino]ethyl]-, (2S,3R,4S)- (9CI)
|
|
653570-93-5
|
C10H22N2O3
|
|
3,4-Pyrrolidinediol, 2-[2-(4-morpholinyl)ethyl]-, (2S,3R,4S)- (9CI)
|
|
653570-94-6
|
C10H20N2O3
|
|
3,4-Pyrrolidinediol,2-[2-(phenylamino)ethyl]-,(2R,3S,4R)-(9CI)
|
|
653571-00-7
|
C12H18N2O2
|
|
3,4-Pyrrolidinediol, 2-[2-(4-morpholinyl)ethyl]-, (2R,3S,4R)- (9CI)
|
|
653571-02-9
|
C10H20N2O3
|
|
3,4-Pyrrolidinediol, 2-[2-[(4-hydroxybutyl)amino]ethyl]-, (2R,3S,4R)- (9CI)
|
|
653571-03-0
|
C10H22N2O3
|
|
3,4-Pyrrolidinediol,2-[2-(phenylamino)ethyl]-,(2S,3S,4R)-(9CI)
|
|
653571-05-2
|
C12H18N2O2
|
|
3,4-Pyrrolidinediol,2-[[(phenylmethyl)amino]methyl]-,(2S,3R,4S)-(9CI)
|
|
653571-07-4
|
C12H18N2O2
|
|
7H-Cyclobuta[d]naphthalen-9-ol,2a,3,5a,6,8,9-hexahydro-,(2aR,5aR,9R)-rel-(9CI)
|
|
653573-00-3
|
C12H16O
|
|
7H-Cyclobuta[d]naphthalen-9-ol,2a,3,5a,6,8,9-hexahydro-(9CI)
|
|
653573-01-4
|
C12H16O
|
|
Sodium Channel inhibitor 2
|
Sodium Channel inhibitor 2
|
653573-60-5
|
C26H25Cl2N3O
|